units

ECX9710

Faculty of Business and Economics

18 September 2017 19 April 2024
Monash University

Postgraduate - Unit

This unit entry is for students who completed this unit in 2012 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 3, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Business and Economics
OfferedClayton Second semester 2012 (Off-campus)
Coordinator(s)Ms Jennifer Watts and Ms Jean Spinks

Synopsis

The economics of the pharmaceutical industry including the market for pharmaceuticals and its regulation internationally and in Australia. Principles of economic evaluation of the costs and outcomes of pharmaceutical products, and provides a guide to best practice with particular emphasis on clinical trials and protocol design.

Outcomes

The learning goals associated with this unit are to:

  1. economic analysis in the pharmaceutical industry
  2. structure of the pharmaceutical industry and the inter-relationship between the nature of the product, market structure and government regulation
  3. impact of government intervention in the pharmaceutical industry including alternative regulatory regimes
  4. role of economic evaluation in promoting the efficient use of drugs
  5. economic analysis of drugs alongside clinical trials, including techniques of health outcome measurement.

Assessment

Within semester assessment: 70%+ Examination (2 hours): 30%

Chief examiner(s)

Mrs Jennifer Watts